Madrigal Pharmaceuticals, Inc.
MDGL
Rank in Stocks
#2000
Madrigal Pharmaceuticals, Inc. is a biopharmaceutical company in the clinical... Madrigal Pharmaceuticals, Inc. is a biopharmaceutical company in the clinical development phase, concentrating its efforts on discovering and commercializing innovative treatments for cardiovascular, metabolic, and liver disorders. Its most advanced drug candidate, resmetirom, functions as a liver-targeted selective thyroid hormone receptor-ß agonist, currently undergoing late-stage (Phase III) clinical trials for managing non-alcoholic steatohepatitis (NASH). The company's pipeline also features MGL-3745, which serves as a secondary or backup compound to resmetirom. Madrigal holds a collaborative agreement with Hoffmann-La Roche, encompassing research, development, and commercialization activities. The company's operations are based out of West Conshohocken, Pennsylvania.
Share Price
$451.08
Last synced: 2026-10-16
Market Cap
$10.42B
Change (1 day)
-1.90%
Change (1 year)
2.77%
Country
US
Trade Madrigal Pharmaceuticals, Inc. (MDGL)
Category
Healthcare
Operating Margin for Madrigal Pharmaceuticals, Inc. (MDGL)
Operating Margin as of October 2026 TTM: -25.13%
According to Madrigal Pharmaceuticals, Inc. latest financial reports and stock price the company's current Operating Margin (TTM) is -25.13%. At the end of 2023 the company had an Operating Margin of 0.00%.
Operating Margin history for Madrigal Pharmaceuticals, Inc. from 2001 to 2026
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2026 (TTM) | -25.13% | -90.91% |
| 2024 | -276.39% | 0.00% |
| 2023 | 0.00% | 0.00% |
| 2022 | 0.00% | 0.00% |
| 2021 | 0.00% | 0.00% |
| 2020 | 0.00% | 0.00% |
| 2019 | 0.00% | 0.00% |
| 2018 | 0.00% | 0.00% |
| 2017 | 0.00% | 0.00% |
| 2016 | 0.00% | 0.00% |
| 2015 | 0.00% | 0.00% |
| 2014 | 0.00% | 0.00% |
| 2013 | 0.00% | 0.00% |
| 2012 | 0.00% | -100.00% |
| 2011 | -599.05% | 140.33% |
| 2010 | -249.26% | -546.38% |
| 2009 | 55.84% | -101.56% |
| 2008 | -3,583.48% | -59.79% |
| 2007 | -8,911.98% | 0.00% |
| 2006 | 0.00% | 0.00% |
| 2005 | 0.00% | -100.00% |
| 2004 | -26,211.56% | 1,108.02% |
| 2003 | -2,169.79% | 0.00% |
| 2002 | 0.00% | 0.00% |
| 2001 | 0.00% | 0.00% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin Difference | Country |
|---|---|---|---|
| 38.59% | -101.54% |
US
|
|
| -149.01% | -94.07% |
US
|
|
| 25.57% | -101.02% |
AU
|
|
| 0.00% | - |
CH
|
|
| 28.81% | -101.15% |
NL
|
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.